The purpose of this clinical trial is to compare a new myopia control spectacle lens with a standard single vision spectacle lens in slowing the progression of myopia (nearsightedness) in healthy children aged 6 to under 11 years. The main question being studied is: Is the new myopia control spectacle lens more effective than a standard single vision spectacle lens in slowing myopia progression? In this study, participants will wear a myopia control spectacle lens in one eye and a standard single vision spectacle lens in the other eye for the first 6 months. The lens assignment will then be switched between eyes for the remaining 6 months. Researchers will compare changes in eye axial length and refractive error between the two lens types. Participants will: * Wear the study spectacles for 12 months. * Attend scheduled follow-up visits at the Essilor R\&D Centre, Singapore.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
A spectacle lens designed to help slow the progression of myopia in children
A standard spectacle lens used to correct refractive error without a specific myopia control feature
Essilor R&D Centre Singapore
Singapore, Singapore
Change in Eye Axial Length
Time frame: From baseline to 6 months
Change in Eye Axial Length
Time frame: From 6 months to 12 months
Change in Eye Non-Cycloplegic Spherical Equivalent Refraction
Time frame: From baseline to 6 months
Change in Eye Non-Cycloplegic Spherical Equivalent Refraction
Time frame: From 6 months to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.